Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Cash & Current Investments (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Cash & Current Investments for 6 consecutive years, with $18.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 63.8% to $18.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.4 million through Dec 2025, down 63.8% year-over-year, with the annual reading at $18.4 million for FY2025, 63.8% down from the prior year.
  • Cash & Current Investments hit $18.4 million in Q4 2025 for Rapid Micro Biosystems, down from $22.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $221.0 million in Q3 2021 to a low of $13.1 million in Q2 2025.
  • Historically, Cash & Current Investments has averaged $73.1 million across 5 years, with a median of $65.9 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: soared 605.05% in 2022 and later crashed 81.09% in 2025.
  • Year by year, Cash & Current Investments stood at $15.4 million in 2021, then skyrocketed by 605.05% to $108.6 million in 2022, then decreased by 15.27% to $92.1 million in 2023, then tumbled by 44.89% to $50.7 million in 2024, then plummeted by 63.8% to $18.4 million in 2025.
  • Business Quant data shows Cash & Current Investments for RPID at $18.4 million in Q4 2025, $22.4 million in Q3 2025, and $13.1 million in Q2 2025.